Veracyte (VCYT) Tax Provisions (2021 - 2026)

Veracyte has disclosed Tax Provisions across 6 years of filings, most recently posting $1.3 million for Q1 2026.

• Tax Provisions for Q1 2026 came in at $1.3 million, up 241.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (up 34.76% YoY), and the FY2025 annual result was $1.8 million, up 15.07% from the prior year.
• Tax Provisions came in at $1.3 million for Q1 2026 at Veracyte, up from -$515000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $2.2 million in Q2 2025 to a low of -$2.2 million in Q4 2023.
• The 5-year median for Tax Provisions is -$23500.0 (2022), against an average of $163625.0.
• Across the five-year window, Tax Provisions plunged 640.69% in 2023 and surged 1201.6% in 2024, its largest moves.
• Veracyte's Tax Provisions stood at $403000.0 in 2022, then slumped by 640.69% to -$2.2 million in 2023, then advanced by 23.36% to -$1.7 million in 2024, then soared by 69.16% to -$515000.0 in 2025, then soared by 352.43% to $1.3 million in 2026.
• The last three Tax Provisions figures came in at $1.3 million (Q1 2026), -$515000.0 (Q4 2025), and -$248000.0 (Q3 2025), per Business Quant data.